Kohlberg & Company Recapitalizes Trinity Life Sciences

First Capital Partners and Rotunda Capital Recapitalize Trinity3 Technology

November 19, 2019

Education

First Capital Partners has completed a debt and equity co-investment in Trinity3 Technology to support Rotunda Capital Partners' recapitalization of the business. Trinity3, based in St. Paul, Minnesota, is a value‑added reseller of tablets, laptops, PCs and related support services serving the K‑12 market across the United States.

Trinity Hunt Partners Recapitalizes Keste

June 17, 2020

IT Services

Trinity Hunt Partners has acquired a majority stake in Keste, a Plano, Texas–based provider of B2B digital transformation and cloud services. The recapitalization will partner Trinity Hunt with Keste founders (who remain significant shareholders) to accelerate growth and scale the business through add-on acquisitions and expanded capabilities.

Trinity Life Sciences Acquires CBPartners

October 7, 2021

Healthcare Services

Trinity Life Sciences has acquired New York–headquartered CBPartners to significantly scale its Value, Access and Pricing business, adding over 75 dedicated experts and expanding Trinity's presence in New York City, San Francisco and London. The acquisition augments Trinity's market access, pricing and commercial strategy capabilities to better support life sciences companies in bringing products to market and ensuring patient access globally.

Oak Hill Capital Partners Acquires Trinity Consultants from Levine Leichtman Capital Partners

June 29, 2021

Environmental Services

Oak Hill Capital, together with Trinity management and employee shareholders, acquired Trinity Consultants from Levine Leichtman Capital Partners. Trinity Consultants, headquartered in Dallas, Texas, is a leading EHS, engineering and science consulting firm serving industrial, healthcare and other end markets globally; financial terms were not disclosed.

Biosynth Acquires Fitzgerald Industries Life Sciences Supply Business from Trinity Biotech for $30M

April 20, 2023

Biotechnology

Biosynth (backed by KKR and Ampersand Capital Partners) has agreed to acquire Trinity Biotech’s Fitzgerald life sciences supply business — comprising Benen Trading Ltd and Fitzgerald Industries International, Inc — for approximately $30 million in cash. Trinity Biotech pursued the divestiture to focus on diabetes care and decentralized diagnostics while reducing net debt; the Fitzgerald business generated about $12 million of revenue in 2022 and will be integrated into Biosynth’s global reagents and biologics platform.

RLG Capital & Trinity Investors Recapitalize eLearning Brothers to Acquire Trivantis and Edulence (KnowledgeLink)

May 3, 2020

Education

RLG Capital and Trinity Investors led a $38 million recapitalization of learning-technology company eLearning Brothers, with co-investors HCAP Partners and Eagle Marsh Holdings and senior debt provided by KeyBank. The financing enables eLearning Brothers to simultaneously acquire Trivantis and Edulence (KnowledgeLink), combining authoring tools (Lectora), VR builder (CenarioVR), an LMS (KnowledgeLink) and content/licensing into an integrated corporate learning platform.